113 related articles for article (PubMed ID: 18481385)
1. Deficient T(H)-1 responses from TNF-alpha-matured and alpha-CD40-matured dendritic cells.
Decker WK; Li S; Xing D; Robinson SN; Yang H; Steiner D; Komanduri KV; Bollard CM; Shpall EJ
J Immunother; 2008; 31(2):157-65. PubMed ID: 18481385
[TBL] [Abstract][Full Text] [Related]
2. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
4. The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?
Lee JJ; Takei M; Hori S; Inoue Y; Harada Y; Tanosaki R; Kanda Y; Kami M; Makimoto A; Mineishi S; Kawai H; Shimosaka A; Heike Y; Ikarashi Y; Wakasugi H; Takaue Y; Hwang TJ; Kim HJ; Kakizoe T
Stem Cells; 2002; 20(5):448-59. PubMed ID: 12351815
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation.
Kaliński P; Schuitemaker JH; Hilkens CM; Kapsenberg ML
J Immunol; 1998 Sep; 161(6):2804-9. PubMed ID: 9743339
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.
Peng JC; Hyde C; Pai S; O'Sullivan BJ; Nielsen LK; Thomas R
J Immunother; 2006; 29(6):606-15. PubMed ID: 17063123
[TBL] [Abstract][Full Text] [Related]
7. Human CD8⁺ T cells drive Th1 responses through the differentiation of TNF/iNOS-producing dendritic cells.
Chong SZ; Wong KL; Lin G; Yang CM; Wong SC; Angeli V; Macary PA; Kemeny DM
Eur J Immunol; 2011 Jun; 41(6):1639-51. PubMed ID: 21469104
[TBL] [Abstract][Full Text] [Related]
8. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines.
Takahashi A; Kono K; Ichihara F; Sugai H; Fujii H; Matsumoto Y
Cancer Immunol Immunother; 2004 Jun; 53(6):543-50. PubMed ID: 14666382
[TBL] [Abstract][Full Text] [Related]
11. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
[TBL] [Abstract][Full Text] [Related]
12. Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2.
Karlsen M; Hovden AO; Vogelsang P; Tysnes BB; Appel S
Scand J Immunol; 2011 Aug; 74(2):135-43. PubMed ID: 21449940
[TBL] [Abstract][Full Text] [Related]
13. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
14. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
15. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α or LPS.
Landi A; Babiuk LA; van Drunen Littel-van den Hurk S
Immunobiology; 2011 Jun; 216(6):649-62. PubMed ID: 21183242
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells.
Cathelin D; Met Ö; Svane IM
Cytotherapy; 2013 Jun; 15(6):740-9. PubMed ID: 23643305
[TBL] [Abstract][Full Text] [Related]
18. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
19. Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response.
Vegh Z; Mazumder A
Cancer Immunol Immunother; 2003 Feb; 52(2):67-79. PubMed ID: 12594570
[TBL] [Abstract][Full Text] [Related]
20. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]